Fosun International Profit Jumps 160.3% to RMB1.72 Billion in H1 2026
HONG KONG -- September 01, 2026 -- Fosun International reported a 160.3% year-on-year surge in first-half profit attributable to owners of the parent to RMB1.72 billion, the conglomerate said at an interim results presentation held in Hong Kong on Aug. 28. Total revenue for the six-month period reached RMB86.96 billion, with overseas markets contributing RMB49.16 billion, or 56.5% of the total. The briefing marked Fosun's first in-person results presentation in Hong Kong in six years, attended by Chairman Guo Guangchang, Co-Chairman Wang Qunbin, Co-CEOs Chen Qiyu and Xu Xiaoliang, and CFO Gong Ping.
Four Core Units Generate 73.5% of Group Revenue
Fosun Pharma, Yuyuan, Portuguese insurer Fidelidade, and the group's tourism segment together accounted for 73.5% of total revenue in the first half, the company disclosed. Pharmaceutical and insurance operations delivered the strongest performance among the four units.